The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Toronto Dominion Bank

Toronto Dominion Bank boosted its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 15.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 66,772 shares of the medical device company's stock after buying an additional 8,900 shares during the period. Toronto Dominion Bank's holdings in Cooper Companies were worth $7,368,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Innealta Capital LLC purchased a new stake in Cooper Companies during the second quarter worth about $25,000. Ashton Thomas Securities LLC acquired a new stake in Cooper Companies during the 3rd quarter worth approximately $25,000. Crewe Advisors LLC lifted its holdings in Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock worth $30,000 after buying an additional 252 shares in the last quarter. Tortoise Investment Management LLC boosted its position in Cooper Companies by 75.4% in the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company's stock valued at $34,000 after buying an additional 169 shares during the period. Finally, Covestor Ltd grew its stake in shares of Cooper Companies by 144.9% in the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after acquiring an additional 200 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Insider Activity

In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares of the company's stock, valued at $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 2.00% of the company's stock.

Cooper Companies Stock Down 1.9 %

NASDAQ:COO traded down $1.87 during midday trading on Friday, hitting $94.85. 1,779,826 shares of the company were exchanged, compared to its average volume of 1,163,765. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The company has a market capitalization of $18.93 billion, a PE ratio of 48.64, a price-to-earnings-growth ratio of 2.52 and a beta of 0.97. The company has a fifty day simple moving average of $103.49 and a 200 day simple moving average of $98.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business's quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.87 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on COO shares. Citigroup reduced their price objective on Cooper Companies from $116.00 to $115.00 and set a "buy" rating on the stock in a research note on Friday, December 6th. Wells Fargo & Company lifted their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, December 6th. Robert W. Baird upped their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, August 29th. Piper Sandler raised their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an "overweight" rating in a report on Thursday, August 29th. Finally, Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.